Goldstein David S. 4

4 · Obagi Medical Products, Inc. · Filed May 14, 2010

Form 4

Period: 2010-05-12

Executive Vice President

Transactions

Exercise/Conversion
Employee Stock Option (right to buy)
2010-05-12−41,667→ 208,751 total
Exercise: $8.40Exp: 2015-03-01→ Common Stock (41,667 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2010-05-12−150→ 208,601 total
Exercise: $10.80Exp: 2015-10-31→ Common Stock (150 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2010-05-13−8,184→ 200,417 total
Exercise: $10.80Exp: 2015-10-31→ Common Stock (8,184 underlying)
Exercise/Conversion
Common Stock
2010-05-12$8.40/sh+41,667$350,003→ 64,167 total
Exercise/Conversion
Common Stock
2010-05-12$10.80/sh+150$1,620→ 64,317 total
Sale
Common Stock
2010-05-12$13.63/sh−41,817$569,928→ 22,500 total
Exercise/Conversion
Common Stock
2010-05-13$10.80/sh+8,184$88,387→ 30,684 total
Exercise/Conversion
Common Stock
2010-05-13$10.00/sh+417$4,170→ 31,101 total
Sale
Common Stock
2010-05-13$13.55/sh−8,601$116,570→ 22,500 total
Exercise/Conversion
Employee Stock Option (right to buy)
2010-05-13−417→ 200,000 total
Exercise: $10.00Exp: 2011-03-31→ Common Stock (417 underlying)

Footnotes (3)

[F1]Such transaction was executed in multiple trades at prices ranging from $13.42 to $13.91. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the trades were effected.
[F2]Such transaction was executed in multiple trades at prices ranging from $13.50 to $13.64. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the trades were effected.
[F3]Fully vested and immediately exercisable.

Documents

1 file